The Enterprise Value as of December 2025 (TTM) for Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS) is 7.25B

According to Zhejiang Ausun Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.25B. This represents a change of 4.03% compared to the average of 6.97B of the last 4 quarters.

Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS) Historical Enterprise Value (quarterly & annually)

How has 603229.SS Enterprise Value performed in the past?

The mean historical Enterprise Value of Zhejiang Ausun Pharmaceutical Co., Ltd. over the last ten years is 3.94B. The current 7.25B Enterprise Value has changed 18.33% with respect to the historical average. Over the past ten years (40 quarters), 603229.SS's Enterprise Value was at its highest in in the December 2021 quarter at 10.00B. The Enterprise Value was at its lowest in in the June 2016 quarter at 0.

Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Zhejiang Ausun Pharmaceutical Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS) Average Enterprise Value

How has 603229.SS Enterprise Value performed in the past?

The current Enterprise Value of Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS) Enterprise Value vs. Peers

How is 603229.SS’s Enterprise Value compared to its peers?

Zhejiang Ausun Pharmaceutical Co., Ltd.’s Enterprise Value is less than Anhui Huaheng Biotechnology Co., Ltd. (10.34B), less than Hunan Jiudian Pharmaceutical Co., Ltd. (7.80B), less than Guilin Sanjin Pharmaceutical Co., Ltd. (8.03B), less than Kexing Biopharm Co., Ltd. (7.43B), less than Aurisco Pharmaceutical Co.,Ltd. (9.41B), less than PharmaBlock Sciences (Nanjing), Inc. (7.70B), less than Daan Gene Co., Ltd. (8.17B), greater than Wuhan Keqian Biology Co.,Ltd (6.93B), less than Chengzhi Shareholding Co., Ltd. (13.47B), less than Chengdu Kanghua Biological Products Co., Ltd. (9.42B),

Build a custom stock screener for Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zhejiang Ausun Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Zhejiang Ausun Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.